Antagonism of the gastrointestinal ulcerogenic effect of some nonsteroidal anti-inflammatory agents by sodium salicylate.
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D000897:Anti-Ulcer Agents; D004305:Dose-Response Relationship, Drug; D005260:Female; D007213:Indomethacin / Q000009:adverse effects / Q000037:antagonists & inhibitors; D007421:Intestine, Small / Q000502:physiology; D008297:Male; D010437:Peptic Ulcer / Q000139:chemically induced / Q000517:prevention & control; D051381:Rats; D012980:Sodium Salicylate / Q000494:pharmacology*; D013276:Stomach Ulcer / Q000139:chemically induced / Q000517:prevention & control; D013718:Tensile Strength / Q000187:drug effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D012980:Sodium Salicylate; D007213:Indomethacin